<DOC>
	<DOC>NCT00808015</DOC>
	<brief_summary>The purpose of this study is to describe the characteristics of the smoker who wants to quit and his/her treating physician, in addition to determine the safety and effectiveness of Champix in the real-world setting of smokers in routine clinical practice.</brief_summary>
	<brief_title>ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking</brief_title>
	<detailed_description>Sampling Method Description: Patients enrolled after being prescribed Champix for smoking cessation at the sole discretion of treating physician and patient.</detailed_description>
	<mesh_term>Varenicline</mesh_term>
	<criteria>All patients enrolled should meet the usual prescribing criteria for Champix® as per the local product information and should be entered into the trial at the investigator's discretion All patients enrolled should meet the usual prescribing criteria for Champix® as per the local product information and should be entered into the trial at the investigator's discretion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Observational non-interventional trial</keyword>
</DOC>